Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72401 - 72425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	PRSS35	167681	downregulated	Silicon Dioxide analog results in decreased expression of PRSS35 mRNA	6q14.2	A24195
Silicon dioxide	Approved	PRSS37	136242	downregulated	Silicon Dioxide analog results in decreased expression of PRSS37 mRNA	7q34	A24195
Silicon dioxide	Approved	PRSS38	339501	downregulated	Silicon Dioxide analog results in decreased expression of PRSS38 mRNA	1q42.13	A24194
Silicon dioxide	Approved	PRTN3	5657	downregulated	Silicon Dioxide analog results in decreased expression of PRTN3 mRNA	19p13.3	A24195
Silicon dioxide	Approved	PRY2	442862	downregulated	Silicon Dioxide analog results in decreased expression of PRY2 mRNA	Yq11.223	A24195
Silicon dioxide	Approved	PSAT1	29968	downregulated	Silicon Dioxide analog results in decreased expression of PSAT1 mRNA	9q21.2	A24194
Silicon dioxide	Approved	PSAT1	29968	downregulated	Silicon Dioxide results in decreased expression of PSAT1 mRNA	9q21.2	A24196
Silicon dioxide	Approved	PSCA	8000	upregulated	Silicon Dioxide analog results in increased expression of PSCA mRNA	8q24.3	A24195
Silicon dioxide	Approved	PSD4	23550	downregulated	Silicon Dioxide analog results in decreased expression of PSD4 mRNA	2q14.1	A24195
Silicon dioxide	Approved	PSG1	5669	upregulated	Silicon Dioxide analog results in increased expression of PSG1 mRNA	19q13.2	A24195
Silicon dioxide	Approved	PSG1	5669	upregulated	Silicon Dioxide results in increased expression of PSG1 mRNA	19q13.2	A24196
Silicon dioxide	Approved	PSG11	5680	downregulated	Silicon Dioxide analog results in decreased expression of PSG11 mRNA	19q13.31	A24195
Silicon dioxide	Approved	PSG3	5671	upregulated	Silicon Dioxide results in increased expression of PSG3 mRNA	19q13.2	A24196
Silicon dioxide	Approved	PSG4	5672	upregulated	Silicon Dioxide results in increased expression of PSG4 mRNA	19q13.31	A24196
Silicon dioxide	Approved	PSG5	5673	upregulated	Silicon Dioxide results in increased expression of PSG5 mRNA	19q13.31	A24196
Silicon dioxide	Approved	PSG6	5675	upregulated	Silicon Dioxide results in increased expression of PSG6 mRNA	19q13.31	A24196
Silicon dioxide	Approved	PSG7	5676	upregulated	Silicon Dioxide results in increased expression of PSG7 mRNA	19q13.31	A24196
Silicon dioxide	Approved	PSG8	440533	upregulated	Silicon Dioxide analog results in increased expression of PSG8 mRNA	19q13.2	A24195
Silicon dioxide	Approved	PSG9	5678	upregulated	Silicon Dioxide results in increased expression of PSG9 mRNA	19q13.31	A24196
Silicon dioxide	Approved	PSMB9	5698	upregulated	Silicon Dioxide analog results in increased expression of PSMB9 mRNA	6p21.32	A24195
Silicon dioxide	Approved	PSMB9	5698	upregulated	Silicon Dioxide results in increased expression of PSMB9 mRNA	6p21.32	A24196
Silicon dioxide	Approved	PSMC3IP	29893	upregulated	Silicon Dioxide analog results in increased expression of PSMC3IP mRNA	17q21.2	A24195
Silicon dioxide	Approved	PSMD11	5717	upregulated	Silicon Dioxide results in increased expression of PSMD11 mRNA	17q11.2	A24196
Silicon dioxide	Approved	PSMD12	5718	upregulated	Silicon Dioxide analog results in increased expression of PSMD12 mRNA	17q24.2	A24195
Silicon dioxide	Approved	PSMD5-AS1	253039	downregulated	Silicon Dioxide analog results in decreased expression of PSMD5-AS1 mRNA	9q33.2	A24195

Displaying entries 72401 - 72425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability